Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
This overview explains risk parity investing and how allocating risk rather than capital can influence retirement portfolio stability.
26,917 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Geopolitical tensions push crypto markets into risk-off mode as XRP faces volatility. This report analyzes price scen...
Cavco stock rose about 9% over the past year even as a large fund pulled roughly $12 million in Cavco shares. This ar...
Investors are weighing the upside of autonomous trucking against cost, timing, and risk. This article breaks down the...
The VIX eased toward the mid-20s as equities edged higher and oil spiked on geopolitical tensions. Analysts say the m...
Bitcoin dropped below the $67,000 level as U.S. Treasury yields climbed toward yearly highs, igniting a risk-off shak...
Iran's Kharg Island oil terminal has halted loading for multiple days as President Trump arrives in Beijing. The disr...
A fresh briefing from the Joint Economic Committee shows Medicare Advantage overpayments totaling about $7 billion pe...
As AI accelerates, the question for investors is clear: will Verisk's valuable data keep its edge or fade into a sea ...
Bitcoin steadies around the $63,000 mark as investors weigh how quantum computing could shake traditional banking cry...
In this morning minute, crypto markets buckled as hawkish Fed signals raised rate hike odds. We unpack the drivers, s...
Tech stocks led the rebound as tensions eased, lifting the Nasdaq while broad indices followed. Here’s what happened,...